SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015980
Filing Date
2021-11-15
Accepted
2021-11-15 16:15:13
Documents
13
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20211115x8k.htm   iXBRL 8-K 33198
2 EX-99.1 ibio-20211115xex99d1.htm EX-99.1 226503
  Complete submission text file 0001558370-21-015980.txt   391107

Data Files

Seq Description Document Type Size
3 EX-101.SCH ibio-20211115.xsd EX-101.SCH 2769
4 EX-101.LAB ibio-20211115_lab.xml EX-101.LAB 13526
5 EX-101.PRE ibio-20211115_pre.xml EX-101.PRE 10122
6 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20211115x8k_htm.xml XML 4667
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 211410783
SIC: 2834 Pharmaceutical Preparations